Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Prolife Industries's Enterprise Value for the quarter that ended in Mar. 2025 was ₹752.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prolife Industries's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹66.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolife Industries EV-to-EBIT Related Terms
Prolife Industries EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Prolife Industries's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Prolife Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prolife Industries EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Prolife Industries's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Prolife Industries's EV-to-EBIT falls into.
Prolife Industries's current Enterprise Value is ₹206.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prolife Industries's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹66.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prolife Industries (NSE:PROLIFE) has a EV-to-EBIT of 3.10 as of Aug. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Prolife Industries and its competitors.
Is Prolife Industries' EV-to-EBIT too high?
Prolife Industries' current EV-to-EBIT is 3.10. The Chemicals industry median EV-to-EBIT is 17.75. Prolife Industries' value of 3.10 is 82.5% below this industry median. Overall, Prolife Industries has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Prolife Industries' EV-to-EBIT compare to DOW?
Prolife Industries' EV-to-EBIT of 3.10 can be compared against companies in the Chemicals industry. The industry median EV-to-EBIT is 17.75. Prolife Industries' value of 3.10 is 82.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.75, based on 1,248 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prolife Industries's current EV-to-EBIT of 3.10 is 82.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Prolife Industries and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prolife Industries's current EV-to-EBIT is 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prolife Industries stock overvalued right now?
Prolife Industries (NSE:PROLIFE) has a current EV-to-EBIT of 3.10. The current EV-to-EBIT is 3.10 and 82.5% below the Chemicals industry median of 17.75. Prolife Industries' overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Prolife Industries (NSE:PROLIFE), the current EV-to-EBIT is 3.10 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Prolife Industries Ltd is engaged in the business of manufacturing of intermediates for dyes, pigments, pharmaceuticals, agrochemicals, and others. Its products include Dihydro Thio Para Toluidine Sulfonic Acid, Amino Methyl Phenoxy Sulfonic Acid, and others. The company derives revenue from both domestic and overseas markets, which are considered different geographical segments.
61GF Score
Get the complete analysis for NSE:PROLIFE
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:PROLIFE has been successfully added to your 
